Back

Effects of empagliflozin on cardiac function in patients with type 2 diabetes mellitus: echocardiographic substudy of the EMPA-HEART cardiolink-6 trial

1 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 2 - Echo cardiomyopathy Systolic and Diastolic Function ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Karan Bami

St. Michael's Hospital, Toronto (Canada)

9 More presentations in this session

Presentation thumbnail
Associate Professor I. Colluoglu (Izmir, TR)
Abstract
Presentation thumbnail
Doctor K. Hirasawa (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Professor N. Mansencal (Boulogne-Billancourt, FR)
Abstract
Presentation thumbnail
Mr Y. Arakawa (Sagamihara, JP)
Abstract
Presentation thumbnail
Doctor A. Kaushik (Jodhpur, IN)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Echo cardiomyopathy

The Event

Event poster

ESC Congress 2019

1 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Session
Recent advances in clinical practice guidelines: what the imager needs to know and apply - Part 2
thumbnail
Congress Presentation
Diastolic function and left atrial pressures
thumbnail
Congress Presentation
Threshold values for diastolic dysfunction parameters indicative of increased mortality risk in a real-world patient cohort

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources